• E-Refill
  • Book a Review
  • Locations
  • Careers
  • About PDC
YOUR HEALTH IS OUR #1 PRIORITY
×
  • Home
  • Benefits
  • About
  • Services
  • Speak to a Doctor
    • Register
    • Book an Appointment
  • News
    • Blog Posts
  • Key Links
  • Need to Know

Peguis Pharmacies Receive Shipment of COVID-19 Vaccines

Peguis Pharmacies Receive Shipment of COVID-19 Vaccines
March 12, 2021Blog Posts

We are pleased to announce that all our pharmacy locations have received doses of COVID-19 vaccines. However; due to the short supply, individuals must meet the criteria to be eligible must phone their local Peguis Pharmacy to make an appointment.

Please download and fill out the COVID-19 Consent FormDownload
COVID-19 Enhanced Consent FormDownload

The (standard) COVID-19 Immunization Consent Form MUST be completed prior to completing this Enhanced Consent Form. Individuals who are pregnant, planning to become pregnant or breastfeeding; immunosuppressed due to disease or treatment and/or have an autoimmune condition are to complete two consent forms.

Eligibility Criteria

As part of the piloted roll-out of the AstraZeneca/Covishield, Manitobans aged 50 to 64 years (First Nations people aged 30 to 64) with a high-risk condition will be the first group eligible to receive the AstraZeneca/Covishield COVID-19 vaccine. These individuals are at increased risk of experiencing serious illness requiring hospitalization or death related to COVID-19.

Anyone who is ALREADY eligible for the Pfizer/Moderna COVID-19 vaccine (such as health care workers) and is aged 18 to 64 is also eligible to receive AstraZeneca/ Covishield COVID-19 vaccine.

However, anyone who has already received a dose of the Pfizer or Moderna mRNA vaccines must use the same product for their second dose, and should not receive the AstraZeneca/Covishield vaccine.

People with high-risk conditions (as determined by their doctor or pharmacist) will be prioritized, with those who have a condition in Priority List 1 being offered immunization before those with a condition in Priority List 2.

Priority List 1:

  • Individuals with the following chronic health conditions:
    • end stage renal disease undergoing hemodialysis OR peritoneal dialysis
    • cirrhosis due to any cause OR portal hypertension
    • heart failure (class III/IV ), ventricular assist device OR adult congenital heart disease stage C and D
    • severe COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease OR cystic fibrosis
    • history of cerebral vascular accident with residual deficits
    • malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
    • malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
    • severe obesity (BMI ≥ 40)
    • receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
    • solid organ or hematopoietic stem cell transplant (candidate or recipient)
    • trisomy 21 (Down syndrome)
    • asplenia or hyposplenism (including sickle cell disease)
  • Individuals receiving home care ≥ 4 times/week OR receive 24/7 support from Community Living Disability Services.
  • Pregnant individuals (18 to ≤ 64 years of age) with one of: aged ≥ 35 years, BMI ≥ 30, pre-existing diabetes, pre-existing hypertension, cardiac or pulmonary disease.

Priority List 2:

  • Individuals with the following chronic health conditions:
    • Chronic cardiovascular disease including heart failure (class I/II), coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
    • chronic liver disease
    • chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson’s disease, multiple sclerosis, ALS OR dementia (including Alzheimer’s disease)
    • chronic pulmonary disease including COPD OR severe and/or uncontrolled asthma
    • chronic renal disease
    • HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
    • severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
    • type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
    • active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
    • receiving immunosuppressing therapy
  • Individuals receiving homecare ≤ 3 times/week OR any level of Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
  • Household contacts of individuals with Priority 1 chronic health conditions OR designated support person(s) for personal care home residents 

LOCATIONS

Chief Peguis Pharmacy
Peguis Mall
204 645 5935

Peguis Pharmacy – Selkirk
103-620 Manitoba Ave
204 482 8353

Peguis Pharmacy – Winnipeg
102-1065 Portage Ave
204 774 0043

About

Owned and operated by Peguis Development Corp, Peguis Pharmacies has three locations that are all focused on making your health our number one priority!

Come in today and meet one of our pharmacy managers, who will be happy to talk to you about the benefits of switching to Peguis Pharmacies.

Locations

Chief Peguis Pharmacy – Peguis Mall
PO BOX 159
Peguis, MB
Phone: 204-645-5935
Fax: 204-645-5949
[email protected]

Peguis Pharmacy – Selkirk
103-620 Manitoba Ave
Selkirk, MB
Phone: 204-482.8353
Fax: 204-482.8378
[email protected]

Peguis Pharmacy – Winnipeg
102-1065 Portage Ave
Winnipeg, MB
Phone: 204-774.0043
Fax: 204-774.0104
[email protected]

Latest Articles

  • Selkirk & Winnipeg locations are now offering FREE Flu Vaccines Nov 8

    Please contact your nearest location to book or for more...

  • Enfamil A+ Available at all our Locations with Prescription Oct 26

    We are pleased to announce that Enfamil A+ is available...

  • Paxlovid – COVID 19 Treatment now available at Selkirk & Winnipeg Locations Oct 14

    Peguis Pharmacies are pleased to announce that the COVID-19 treatment,...

  • Nutramigen Now Available at 1065 Portage Pharmacy Jul 21

    Nutramigen with Enflora LGG is clinically proven to manage colic...

  • Telemedicine Walk-In Clinic Now Available May 25

    Peguis Pharmacies is now offering Telemedicine Virtual Walk-In Clinics, Patients...

Owned and operated by Peguis Development Corp, Peguis Pharmacies has three locations that are all focused on making your health our number one priority! Come in today and meet one of our pharmacy managers, who will be happy to talk to you about the benefits of switching to Peguis Pharmacies.

Recent Posts

  • Selkirk & Winnipeg locations are now offering FREE Flu Vaccines Nov 8

    Please contact your nearest location to book or for more...

  • Enfamil A+ Available at all our Locations with Prescription Oct 26

    We are pleased to announce that Enfamil A+ is available...

  • Paxlovid – COVID 19 Treatment now available at Selkirk & Winnipeg Locations Oct 14

    Peguis Pharmacies are pleased to announce that the COVID-19 treatment,...

  • Nutramigen Now Available at 1065 Portage Pharmacy Jul 21

    Nutramigen with Enflora LGG is clinically proven to manage colic...

  • Telemedicine Walk-In Clinic Now Available May 25

    Peguis Pharmacies is now offering Telemedicine Virtual Walk-In Clinics, Patients...

Quick Links

  • E-Refill
  • Book a Review
  • Locations
  • Careers
  • About PDC
Peguis Development Corporation © 2020
Designed & Administrated by Neault Marketing Solution